Absci (ABSI) Capital Expenditures (QoQ) (2020 - 2026)
Absci (ABSI) Capital Expenditures (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 129.13% |
| Dec 31, 2025 | -110.71% |
| Sep 30, 2025 | 331.39% |
| Jun 30, 2025 | 792.00% |
| Mar 31, 2025 | -92.47% |
| Dec 31, 2024 | 227.20% |
| Sep 30, 2024 | -178.38% |
| Sep 30, 2023 | -62.50% |
| Jun 30, 2023 | -138.10% |
| Mar 31, 2023 | 100.81% |
| Dec 31, 2022 | -214.70% |
| Sep 30, 2022 | 1,154.57% |
| Jun 30, 2022 | -139.37% |
| Mar 31, 2022 | 188.56% |
| Dec 31, 2021 | 81.95% |
| Sep 30, 2021 | -185.04% |
| Jun 30, 2021 | 75,546.88% |
| Mar 31, 2021 | -188.89% |
| Dec 31, 2020 | 107.55% |